UNITY Biotechnology Reports Granting of New Employment Inducement Award
December 22 2021 - 8:00AM
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology
company developing therapeutics to slow, halt, or reverse diseases
of aging, today announced that from December 7, 2021, through
December 21, 2021, the Compensation Committee of the Board of
Directors (the “Board”) granted a new employee a stock-based award
covering an aggregate of 4,500 shares of UNITY common stock,
including options to purchase an aggregate of 4,500 shares of UNITY
common stock. The stock-based award was granted pursuant to the
UNITY 2020 Employment Inducement Incentive Plan, as amended, which
was approved by the Board in March 2020 to provide for grants to
newly hired employees as a material inducement for them to commence
employment with UNITY in accordance with Nasdaq Stock Market Rule
5635(c)(4).
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY’s
current focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related ophthalmologic and neurologic diseases.
More information is available
at www.unitybiotechnology.com or follow us
on Twitter and LinkedIn.
Media
Canale Communications
Jason Spark
Jason.spark@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Jun 2024 to Jul 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Jul 2023 to Jul 2024